2024-04-012025-03-312025-03-31falseSC239393LAPAROSCOPIC SURGERY LTD.2026-05-31falseiso4217:GBPxbrli:pureSC2393932024-03-31SC2393932025-03-31SC2393932024-04-012025-03-31SC2393932023-03-31SC2393932024-03-31SC2393932023-04-012024-03-31SC239393bus:SmallEntities2024-04-012025-03-31SC239393bus:AuditExempt-NoAccountantsReport2024-04-012025-03-31SC239393bus:FullAccounts2024-04-012025-03-31SC239393bus:PrivateLimitedCompanyLtd2024-04-012025-03-31SC239393core:WithinOneYear2025-03-31SC239393core:AfterOneYear2025-03-31SC239393core:WithinOneYear2024-03-31SC239393core:AfterOneYear2024-03-31SC239393core:ShareCapital2025-03-31SC239393core:SharePremium2025-03-31SC239393core:RevaluationReserve2025-03-31SC239393core:OtherReservesSubtotal2025-03-31SC239393core:RetainedEarningsAccumulatedLosses2025-03-31SC239393core:ShareCapital2024-03-31SC239393core:SharePremium2024-03-31SC239393core:RevaluationReserve2024-03-31SC239393core:OtherReservesSubtotal2024-03-31SC239393core:RetainedEarningsAccumulatedLosses2024-03-31SC239393core:LandBuildings2025-03-31SC239393core:PlantMachinery2025-03-31SC239393core:Vehicles2025-03-31SC239393core:FurnitureFittings2025-03-31SC239393core:OfficeEquipment2025-03-31SC239393core:NetGoodwill2025-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2025-03-31SC239393core:ListedExchangeTraded2025-03-31SC239393core:UnlistedNon-exchangeTraded2025-03-31SC239393core:LandBuildings2024-03-31SC239393core:PlantMachinery2024-03-31SC239393core:Vehicles2024-03-31SC239393core:FurnitureFittings2024-03-31SC239393core:OfficeEquipment2024-03-31SC239393core:NetGoodwill2024-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2024-03-31SC239393core:ListedExchangeTraded2024-03-31SC239393core:UnlistedNon-exchangeTraded2024-03-31SC239393core:LandBuildings2024-04-012025-03-31SC239393core:PlantMachinery2024-04-012025-03-31SC239393core:Vehicles2024-04-012025-03-31SC239393core:FurnitureFittings2024-04-012025-03-31SC239393core:OfficeEquipment2024-04-012025-03-31SC239393core:NetGoodwill2024-04-012025-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-31SC239393core:ListedExchangeTraded2024-04-012025-03-31SC239393core:UnlistedNon-exchangeTraded2024-04-012025-03-31SC239393core:MoreThanFiveYears2024-04-012025-03-31SC239393core:Non-currentFinancialInstruments2025-03-31SC239393core:Non-currentFinancialInstruments2024-03-31SC239393dpl:CostSales2024-04-012025-03-31SC239393dpl:DistributionCosts2024-04-012025-03-31SC239393core:LandBuildings2024-04-012025-03-31SC239393core:PlantMachinery2024-04-012025-03-31SC239393core:Vehicles2024-04-012025-03-31SC239393core:FurnitureFittings2024-04-012025-03-31SC239393core:OfficeEquipment2024-04-012025-03-31SC239393dpl:AdministrativeExpenses2024-04-012025-03-31SC239393core:NetGoodwill2024-04-012025-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-31SC239393dpl:GroupUndertakings2024-04-012025-03-31SC239393dpl:ParticipatingInterests2024-04-012025-03-31SC239393dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-31SC239393core:ListedExchangeTraded2024-04-012025-03-31SC239393dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-31SC239393core:UnlistedNon-exchangeTraded2024-04-012025-03-31SC239393dpl:CostSales2023-04-012024-03-31SC239393dpl:DistributionCosts2023-04-012024-03-31SC239393core:LandBuildings2023-04-012024-03-31SC239393core:PlantMachinery2023-04-012024-03-31SC239393core:Vehicles2023-04-012024-03-31SC239393core:FurnitureFittings2023-04-012024-03-31SC239393core:OfficeEquipment2023-04-012024-03-31SC239393dpl:AdministrativeExpenses2023-04-012024-03-31SC239393core:NetGoodwill2023-04-012024-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-31SC239393dpl:GroupUndertakings2023-04-012024-03-31SC239393dpl:ParticipatingInterests2023-04-012024-03-31SC239393dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-31SC239393core:ListedExchangeTraded2023-04-012024-03-31SC239393dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-31SC239393core:UnlistedNon-exchangeTraded2023-04-012024-03-31SC239393core:NetGoodwill2025-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2025-03-31SC239393core:LandBuildings2025-03-31SC239393core:PlantMachinery2025-03-31SC239393core:Vehicles2025-03-31SC239393core:FurnitureFittings2025-03-31SC239393core:OfficeEquipment2025-03-31SC239393core:AfterOneYear2025-03-31SC239393core:WithinOneYear2025-03-31SC239393core:ListedExchangeTraded2025-03-31SC239393core:UnlistedNon-exchangeTraded2025-03-31SC239393core:ShareCapital2025-03-31SC239393core:SharePremium2025-03-31SC239393core:RevaluationReserve2025-03-31SC239393core:OtherReservesSubtotal2025-03-31SC239393core:RetainedEarningsAccumulatedLosses2025-03-31SC239393core:NetGoodwill2024-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2024-03-31SC239393core:LandBuildings2024-03-31SC239393core:PlantMachinery2024-03-31SC239393core:Vehicles2024-03-31SC239393core:FurnitureFittings2024-03-31SC239393core:OfficeEquipment2024-03-31SC239393core:AfterOneYear2024-03-31SC239393core:WithinOneYear2024-03-31SC239393core:ListedExchangeTraded2024-03-31SC239393core:UnlistedNon-exchangeTraded2024-03-31SC239393core:ShareCapital2024-03-31SC239393core:SharePremium2024-03-31SC239393core:RevaluationReserve2024-03-31SC239393core:OtherReservesSubtotal2024-03-31SC239393core:RetainedEarningsAccumulatedLosses2024-03-31SC239393core:NetGoodwill2023-03-31SC239393core:IntangibleAssetsOtherThanGoodwill2023-03-31SC239393core:LandBuildings2023-03-31SC239393core:PlantMachinery2023-03-31SC239393core:Vehicles2023-03-31SC239393core:FurnitureFittings2023-03-31SC239393core:OfficeEquipment2023-03-31SC239393core:AfterOneYear2023-03-31SC239393core:WithinOneYear2023-03-31SC239393core:ListedExchangeTraded2023-03-31SC239393core:UnlistedNon-exchangeTraded2023-03-31SC239393core:ShareCapital2023-03-31SC239393core:SharePremium2023-03-31SC239393core:RevaluationReserve2023-03-31SC239393core:OtherReservesSubtotal2023-03-31SC239393core:RetainedEarningsAccumulatedLosses2023-03-31SC239393core:AfterOneYear2024-04-012025-03-31SC239393core:WithinOneYear2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-31SC239393core:Non-currentFinancialInstrumentscore:CostValuation2025-03-31SC239393core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-31SC239393core:Non-currentFinancialInstrumentscore:CostValuation2024-03-31SC239393core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-31SC239393core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-31SC239393core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-31SC239393core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-31SC239393core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-31SC239393core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-31SC239393core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-31SC239393core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-31SC239393bus:Director12024-04-012025-03-31

LAPAROSCOPIC SURGERY LTD.

Registered Number
SC239393
(Scotland)

Unaudited Financial Statements for the Year ended
31 March 2025

LAPAROSCOPIC SURGERY LTD.
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Mr A H M Nassar

Company Secretary

Mrs P A Nassar

Registered Address

29/10 Brighouse Park Cross
Cramond
Edinburgh
EH4 6GW

Registered Number

SC239393 (Scotland)
LAPAROSCOPIC SURGERY LTD.
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3491456
491456
Current assets
Debtors43,611-
Cash at bank and on hand21,83041,346
25,44141,346
Creditors amounts falling due within one year5(19,987)(33,211)
Net current assets (liabilities)5,4548,135
Total assets less current liabilities5,9458,591
Provisions for liabilities(123)(114)
Net assets5,8228,477
Capital and reserves
Called up share capital100100
Profit and loss account5,7228,377
Shareholders' funds5,8228,477
The financial statements were approved and authorised for issue by the Director on 31 May 2026, and are signed on its behalf by:
Mr A H M Nassar
Director
Registered Company No. SC239393
LAPAROSCOPIC SURGERY LTD.
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered office is Flat 10, 29 Brighouse Park Cross, Cramond, Edinburgh, EH4 6GW.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable net of discounts. Medical consultancy fees are recognised when the service is delivered to the customer.
Current taxation
Current tax is recognised in profit or loss account and represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of the assets less their residual values over their useful lives on the following bases: Computers 33.33% straight line Motor vehicles 25% reducing balance The gain or loss arising on the disposal of an asset is determined as the difference between the sales proceeds and the carrying value of the asset, and is credited or charged to the profit and loss account.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately within current liabilities.
Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets like trade and other debtors and creditors. These are measured at amortised cost and are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 244,2614,261
Additions654654
At 31 March 254,9154,915
Depreciation and impairment
At 01 April 243,8053,805
Charge for year619619
At 31 March 254,4244,424
Net book value
At 31 March 25491491
At 31 March 24456456
4.Debtors: amounts due within one year

2025

2024

££
Other debtors3,611-
Total3,611-
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security5,7425,879
Other creditors8,13520,553
Accrued liabilities and deferred income6,1106,779
Total19,98733,211